Logo for Magle Chemoswed Holding

Magle Chemoswed Holding Investor Relations Material

Latest events

Logo for Magle Chemoswed Holding

Q3 2022

Magle Chemoswed Holding
Logo for Magle Chemoswed Holding

Q1 2024

18 Apr, 2024
Logo for Magle Chemoswed Holding

Q4 2023

16 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Magle Chemoswed Holding

Access all reports
Magle Chemoswed Holding AB is a company active in the pharmaceutical and medical device industries, serving as a contract development and manufacturing organization (CDMO). The company is dedicated to offering a wide range of services from development through manufacturing on a contract basis, excelling in bringing innovations from idea to product. Magle Chemoswed operates through its subsidiaries, including Magle Chemoswed AB and Adroit Science AB, focusing on the process development and manufacturing of Active Pharmaceutical Ingredients (API) and the development and manufacturing of products in wound care and diagnostics, particularly those based on degradable starch microspheres. Additionally, it provides consultancy in material characterization and solid-phase analysis, mainly targeting pharmaceutical companies. The company is headquartered in Malmö, Sweden, and its shares are listed on the Nasdaq Stockholm.